InvestorsHub Logo
Followers 18
Posts 1015
Boards Moderated 0
Alias Born 02/13/2013

Re: None

Tuesday, 01/02/2018 12:49:28 AM

Tuesday, January 02, 2018 12:49:28 AM

Post# of 733
http://www.asx.com.au/asx/share-price-research/company/cuv

CUV down AUS $0.30

From Sharescene:
QUOTE:
Google translate of that page suggests that afamelanotide has been added to the Norwegian list of drugs that are not covered by central insurance. Is there a speaker of Norwegian on here that can confirm?

It appears the advice was published at the same time that NICE published it's refusal. I wonder if that is co-incidence, or if they are linked.

I suppose if it is linked to NICE then this too will be part of the ongoing NICE negotiations/litigation.

Not a helpful start to the year".

https://lovdata.no/dokument/SF/forskrift/2017-12-20-2257

Unquote